{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T03:55:57Z","timestamp":1774497357238,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jogc.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jogc.2017.06.038","type":"journal-article","created":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T18:01:14Z","timestamp":1508349674000},"page":"317-327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["The Cost-Effectiveness of Salpingectomies for Family Planning in the Prevention of Ovarian Cancer"],"prefix":"10.1016","volume":"40","author":[{"given":"R.W. Melissa","family":"Tai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie K.Y.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter C.","family":"Coyte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2017.06.038_bib0010","series-title":"Ovarian cancer statistics","author":"American Cancer Society","year":"2015"},{"key":"10.1016\/j.jogc.2017.06.038_bib0015","series-title":"Canadian cancer report","author":"Canadian Cancer Society","year":"2015"},{"key":"10.1016\/j.jogc.2017.06.038_bib0020","first-page":"255","article-title":"Ovarian surface epithelium: biology, endocrinology, and pathology","volume":"22","author":"Auersperg","year":"2001","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jogc.2017.06.038_bib0025","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1001\/jama.2011.766","article-title":"Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial","volume":"305","author":"Buys","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jogc.2017.06.038_bib0030","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogc.2017.06.038_bib0035","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/modpathol.2009.89","article-title":"Candidate serous cancer precursors in fallopian tube epithelium of BRCA1\/2 mutation carriers","volume":"22","author":"Shaw","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jogc.2017.06.038_bib0040","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3121\/cmr.2007.702","article-title":"Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer","volume":"5","author":"Crum","year":"2007","journal-title":"Clin Med Res"},{"key":"10.1016\/j.jogc.2017.06.038_bib0045","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J Pathol"},{"key":"10.1016\/j.jogc.2017.06.038_bib0050","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jogc.2017.06.038_bib0055","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3747\/co.20.1613","article-title":"Preventing ovarian cancer by salpingectomy","volume":"20","author":"Foulkes","year":"2013","journal-title":"Curr Oncol"},{"key":"10.1016\/j.jogc.2017.06.038_bib0060","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/IGC.0b013e318199009c","article-title":"The fallopian tube: primary site of most pelvic high-grade serous carcinomas","volume":"19","author":"Salvador","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jogc.2017.06.038_bib0065","author":"The Society of Gynecologic Oncology of Canada"},{"key":"10.1016\/j.jogc.2017.06.038_bib0070","series-title":"GOC statement regarding salpingectomy and ovarian cancer prevention","author":"The Society of Gynecologic Oncology of Canada","year":"2011"},{"key":"10.1016\/j.jogc.2017.06.038_bib0075","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0015-0282(00)00481-7","article-title":"Tubal sterilization: focus on the U.S. experience","volume":"73","author":"Westhoff","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogc.2017.06.038_bib0080","unstructured":"Ontario Ministry of Health and Long-Term Care. Schedule of Benefits for Physician Services under the Health Insurance Act. Ontario Minist Heal Long-Term Care 2012."},{"key":"10.1016\/j.jogc.2017.06.038_bib0085","series-title":"Toronto east general hospital fiscal budget report 2012\/13","author":"Toronto East General Hospital","year":"2013"},{"key":"10.1016\/j.jogc.2017.06.038_bib0090","series-title":"Toronto east general hospital surgical operative services budget report 2012\/13","author":"Toronto East General Hospital","year":"2013"},{"key":"10.1016\/j.jogc.2017.06.038_bib0095","series-title":"Toronto east general hospital pharmacy services budget report 2012\/13","author":"Toronto East General Hospital","year":"2013"},{"key":"10.1016\/j.jogc.2017.06.038_bib0100","author":"Statistics Canada"},{"key":"10.1016\/j.jogc.2017.06.038_bib0105","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ygyno.2008.12.026","article-title":"Determination of quality of life-related utilities for health states relevant to ovarian cancer diagnosis and treatment","volume":"113","author":"Havrilesky","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogc.2017.06.038_bib0110","first-page":"283","article-title":"The quality of life associated with prophylactic treatments for women with BRCA1\/2 mutations","volume":"5","author":"Grann","year":"1999","journal-title":"Cancer J Sci Am"},{"key":"10.1016\/j.jogc.2017.06.038_bib0115","doi-asserted-by":"crossref","first-page":"397","DOI":"10.7326\/0003-4819-144-6-200603210-00006","article-title":"Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation","volume":"144","author":"Anderson","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jogc.2017.06.038_bib0120","series-title":"Vaccines for the 21st century: a tool for decisionmaking","year":"2000"},{"key":"10.1016\/j.jogc.2017.06.038_bib0125","series-title":"Canadian human mortality database","author":"Universit\u00e9 de Montr\u00e9al","year":"2009"},{"key":"10.1016\/j.jogc.2017.06.038_bib0130","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1056\/NEJM199703133361104","article-title":"The risk of ectopic pregnancy after tubal sterilization. U.S. Collaborative Review of Sterilization Working Group","volume":"336","author":"Peterson","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogc.2017.06.038_bib0135","series-title":"Surveillance epidemiology and end results","author":"National Cancer Institute","year":"2015"},{"key":"10.1016\/j.jogc.2017.06.038_bib0140","first-page":"1","article-title":"Tubal ligation and the risk of ovarian carcinoma","volume":"21","author":"Cornelison","year":"1997","journal-title":"Cancer Detect Prev"},{"key":"10.1016\/j.jogc.2017.06.038_bib0145","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/ije\/dyh046","article-title":"Tubal sterilization and risk of ovarian, endometrial and cervical cancer. A Danish population-based follow-up study of more than 65 000 sterilized women","volume":"33","author":"Kjaer","year":"2004","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jogc.2017.06.038_bib0150","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/oxfordjournals.aje.a009112","article-title":"Tubal ligation and fatal ovarian cancer in a large prospective cohort study","volume":"145","author":"Miracle-McMahill","year":"1997","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jogc.2017.06.038_bib0155","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/ije\/26.4.710","article-title":"Surgical procedures associated with risk of ovarian cancer","volume":"26","author":"Kreiger","year":"1997","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jogc.2017.06.038_bib0160","first-page":"933","article-title":"Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives","volume":"5","author":"Rosenblatt","year":"1996","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jogc.2017.06.038_bib0165","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(00)04642-0","article-title":"Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study","volume":"357","author":"Narod","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jogc.2017.06.038_bib0170","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1200\/JCO.1997.15.2.632","article-title":"Economic and policy implications of adopting paclitaxel as first-line therapy for advanced ovarian cancer: an Ontario perspective","volume":"15","author":"Elit","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jogc.2017.06.038_bib0175","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1200\/JCO.1997.15.3.1000","article-title":"Resource implications of palliative chemotherapy for ovarian cancer","volume":"15","author":"Doyle","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jogc.2017.06.038_bib0180","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/humupd\/dmq030","article-title":"Tubal ligation and the risk of ovarian cancer: review and meta-analysis","volume":"17","author":"Cibula","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.jogc.2017.06.038_bib0185","author":"Statistics Canada"},{"key":"10.1016\/j.jogc.2017.06.038_bib0190","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/AOG.0000000000000630","article-title":"Costs and Benefits of Opportunistic Salpingectomy as an Ovarian Cancer Prevention Strategy","volume":"125","author":"Kwon","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.06.038_bib0195","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1503\/cmaj.090845","article-title":"The cost-effectiveness of screening for colorectal cancer","volume":"182","author":"Telford","year":"2010","journal-title":"CMAJ"},{"key":"10.1016\/j.jogc.2017.06.038_bib0200","series-title":"Cost of a standard hospital stay","author":"Canadian Institute For Health Information","year":"2015"},{"key":"10.1016\/j.jogc.2017.06.038_bib0205","first-page":"1073","article-title":"A comparison of women's regret after vasectomy versus tubal sterilization","volume":"99","author":"Jamieson","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.06.038_bib0210","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0015-0282(16)54301-5","article-title":"Risk factors for regret after tubal sterilization: 5 years of follow-up in a prospective study","volume":"55","author":"Wilcox","year":"1991","journal-title":"Fertil Steril"}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216317304930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216317304930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:29:58Z","timestamp":1761665398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1701216317304930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S1701216317304930"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2017.06.038","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Cost-Effectiveness of Salpingectomies for Family Planning in the Prevention of Ovarian Cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2017.06.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}